#1 Clinical Trials Search in Europe

Acquired antithrombin III deficiency – Diagnostics

Go back

Acquired antithrombin III deficiency is a blood clotting disorder that develops due to certain medical conditions or treatments, making it harder for your body to control blood clot formation naturally.

Introduction

Diagnosing acquired antithrombin III deficiency is important for people who develop unexpected blood clotting problems, especially when they are facing certain medical challenges. Unlike the inherited form of this condition, acquired antithrombin deficiency happens when something in your body causes your antithrombin levels to drop or become less effective. This can occur during serious illnesses or as a side effect of certain treatments.[3]

You should consider seeking diagnostic testing if you develop unusual blood clots, particularly when you have conditions that are known to affect antithrombin levels. People who are hospitalized with severe infections, those with liver problems, individuals undergoing bone marrow transplantation, or patients with kidney disease that causes protein loss should be especially alert to this possibility. Healthcare providers often recommend testing when blood clots appear in unexpected locations or when standard blood thinning medications don’t seem to work as expected.[3][4]

The timing of diagnosis matters greatly. When doctors identify this deficiency early, they can adjust treatment approaches and take steps to prevent dangerous blood clots from forming or growing larger. This is particularly crucial for people undergoing major surgery, those receiving certain cancer treatments, pregnant women, or anyone with conditions that put extra stress on the blood clotting system. Early detection allows medical teams to provide more targeted care and reduce the risk of serious complications like deep vein thrombosis in the legs or pulmonary embolism in the lungs.[3][2]

Diagnostic Methods

The foundation of diagnosing acquired antithrombin III deficiency begins with understanding your complete medical picture. Your healthcare provider will conduct a thorough physical examination and gather detailed information about your medical history. This includes asking about recent illnesses, current medications, surgical procedures, and any symptoms you’ve experienced. The conversation might cover whether you’ve noticed swelling in your legs, chest pain, shortness of breath, or other signs that could indicate blood clotting problems.[2]

The most important diagnostic tool is a blood test that specifically measures antithrombin levels in your body. This test is called an antithrombin assay, which is a laboratory procedure that determines how much functional antithrombin protein is present in your blood. Normal antithrombin levels typically range from 80% to 120% of what is considered standard. When levels fall below this range, it suggests that your body doesn’t have enough antithrombin to properly regulate blood clotting. The blood sample is usually drawn from a vein in your arm and sent to a laboratory for analysis.[3][2]

However, testing for antithrombin deficiency requires careful timing and interpretation. If you’re already taking blood thinning medications like heparin (a common anticoagulant), the test results might not be accurate. Heparin itself can actually lower antithrombin levels, which could lead to confusing results. For this reason, doctors often prefer to perform the test before starting certain treatments, or they may need to consider your medication use when interpreting the results. This makes the timing of the test an important factor in getting useful diagnostic information.[3][4]

⚠️ Important
When testing for acquired antithrombin deficiency, the results must be understood in the context of your overall health situation. Many medical conditions can temporarily lower antithrombin levels, so a single low test result doesn’t automatically mean you have a permanent deficiency. Your doctor will consider factors like active infections, liver function, kidney health, and recent surgeries when evaluating your test results.

In addition to the antithrombin assay, doctors may order several other blood tests to get a complete picture of your clotting system and help distinguish acquired antithrombin deficiency from other blood clotting disorders. These additional tests include prothrombin time (PT) and activated partial thromboplastin time (aPTT), which measure how long it takes for your blood to clot through different pathways. These tests help doctors understand if there are other problems with your clotting system beyond low antithrombin.[3]

Your healthcare team might also check for other natural anticoagulants in your blood. Tests for Protein C and Protein S are common, as deficiencies in these proteins can cause similar symptoms to antithrombin deficiency. Factor V Leiden testing looks for a genetic mutation that increases clotting risk. Blood tests for homocysteine (an amino acid that can increase clotting risk when elevated) and anticardiolipin antibodies (immune system proteins that can promote clotting) help rule out other conditions that might be causing your blood clots.[3]

When blood clots have already formed or are suspected, imaging studies become an essential part of the diagnostic process. Doppler ultrasonography with compression is a painless test that uses sound waves to create pictures of blood flow through your veins. This test is particularly useful for detecting blood clots in the legs, which is one of the most common complications of antithrombin deficiency. The ultrasound technician will press gently on different areas while watching the blood flow on a screen to identify any blockages.[3]

For people with symptoms suggesting blood clots in the lungs, doctors may order a ventilation-perfusion scan, sometimes called a V/Q scan. This imaging test shows whether air and blood are flowing normally through all areas of your lungs. It helps identify pulmonary embolism, which is a potentially life-threatening condition where a blood clot travels to the lungs. The test involves inhaling a small amount of radioactive gas and receiving an injection of a radioactive substance, allowing special cameras to capture images of both air movement and blood flow in your lungs.[3]

In certain situations, particularly if there’s concern about blood clots affecting the heart, an echocardiogram may be recommended. This test uses sound waves to create moving pictures of your heart, allowing doctors to see how well your heart is pumping and whether there are any clots or other abnormalities. This is especially important for people with antithrombin deficiency who develop arterial blood clots, which are less common but potentially very serious. The test is similar to an ultrasound and doesn’t involve any radiation or painful procedures.[3]

The diagnostic process for acquired antithrombin deficiency often involves looking for the underlying cause of the low antithrombin levels. Your doctor will investigate conditions known to cause acquired deficiency, such as disseminated intravascular coagulation (DIC), a serious disorder where blood clots form throughout the body while simultaneously causing dangerous bleeding. Other conditions that may be investigated include liver disease, which affects the production of antithrombin since it’s made in the liver; nephrotic syndrome, a kidney disorder that causes protein loss in urine; and severe infections like sepsis, which can consume antithrombin rapidly.[3][4]

For patients undergoing bone marrow transplantation, doctors may specifically test for antithrombin levels because a condition called veno-occlusive disease can develop, which is associated with decreased antithrombin. Similarly, people taking oral contraceptives or receiving heparin treatment may need monitoring, as these medications have been associated with reduced antithrombin levels in some cases. Understanding what caused your antithrombin to become deficient is crucial for proper treatment and preventing future complications.[3][4]

Diagnostics for Clinical Trial Qualification

When considering participation in clinical trials for conditions related to blood clotting disorders, specific diagnostic tests become necessary to determine if you qualify for the study. Clinical trials testing new treatments for acquired antithrombin deficiency or related conditions require precise measurements to ensure patient safety and study accuracy. The cornerstone of this evaluation remains the antithrombin assay, which must show that your antithrombin levels fall within the range specified by the trial protocol.[3]

Research studies typically require documentation of your complete coagulation profile. This means having recent results from blood tests that measure various aspects of your blood clotting system. Beyond the basic antithrombin measurement, trials often require baseline prothrombin time and activated partial thromboplastin time results to establish your starting point before any experimental treatment begins. These baseline measurements help researchers track how well new treatments work and whether they cause any unexpected changes in your blood clotting ability.[3]

Clinical trials may also require imaging studies to document any existing blood clots before enrollment. If you have a history of deep vein thrombosis or pulmonary embolism, Doppler ultrasonography or ventilation-perfusion scanning results might be needed to show the current status of these clots. This documentation helps researchers understand whether a new treatment helps existing clots resolve or primarily prevents new ones from forming. It also ensures that your current medical condition matches what the study is designed to investigate.[3]

For acquired antithrombin deficiency specifically, clinical trials often require proof of the underlying condition causing the deficiency. This might involve laboratory tests showing evidence of liver disease, kidney function tests demonstrating nephrotic syndrome, or infection markers indicating sepsis. The trial protocol may specify exactly what test results are needed and how recent they must be. Some studies might exclude certain causes of acquired deficiency while focusing on others, making accurate diagnosis of the underlying condition essential for trial eligibility.[3][4]

⚠️ Important
Clinical trials have strict requirements about the timing of diagnostic tests. Test results that are too old may not be accepted, and you might need to repeat certain tests shortly before enrolling in a study. Additionally, some trials require that you stop certain medications before testing to get accurate baseline measurements. Always discuss these requirements thoroughly with the research team before agreeing to participate.

Safety monitoring in clinical trials for blood clotting disorders requires repeated diagnostic testing throughout the study period. This means you’ll likely need regular blood draws to check your antithrombin levels and other clotting factors at scheduled intervals. Some trials might also require periodic imaging studies to monitor for the development of new blood clots or the resolution of existing ones. These repeated tests help researchers determine if the experimental treatment is working safely and effectively.[3]

Prognosis and Survival Rate

Prognosis

The outlook for people with acquired antithrombin III deficiency depends heavily on the underlying condition causing the deficiency and how quickly it can be identified and treated. Unlike inherited forms that are lifelong conditions, acquired deficiency can potentially be reversed if the triggering medical problem improves. For instance, if liver disease or kidney disease is treated successfully, antithrombin levels may return to normal, reducing the risk of future blood clots. However, in cases where the underlying condition is chronic or cannot be fully resolved, such as advanced liver disease or ongoing cancer, the deficiency may persist and require long-term management.[3][4]

The risk of developing blood clots varies depending on several factors. People who develop acquired antithrombin deficiency during hospitalization for serious conditions like sepsis or after major surgery face immediate risks, but these may decrease significantly once they recover from the acute illness. Those with conditions causing chronic deficiency need ongoing monitoring and may require extended treatment with blood thinners to prevent dangerous clotting events. Age also plays a role, as older individuals generally face higher risks of blood clots even without antithrombin deficiency. Additional risk factors include prolonged periods of immobility, surgical procedures, and pregnancy, all of which can compound the clotting risk in people with low antithrombin levels.[2][3]

Survival rate

Specific survival statistics for acquired antithrombin III deficiency are difficult to establish because outcomes depend largely on the severity of the underlying medical condition rather than the deficiency itself. The condition most commonly occurs in people who are already seriously ill with conditions like disseminated intravascular coagulation, severe sepsis, or advanced liver disease. In these situations, the overall prognosis is influenced more by the primary illness than by the antithrombin deficiency alone. However, the presence of antithrombin deficiency can complicate treatment and increase the risk of life-threatening blood clots, which may affect overall outcomes.[3][4]

People who develop blood clots as a result of acquired antithrombin deficiency face risks similar to those with other causes of venous thromboembolism. Deep vein thrombosis can lead to chronic leg swelling and discomfort if not treated promptly. Pulmonary embolism, where a clot travels to the lungs, is a potentially fatal complication that requires immediate medical attention. The good news is that with proper diagnosis, appropriate use of anticoagulant medications, and management of the underlying condition, many people with acquired antithrombin deficiency can avoid these serious complications and maintain good quality of life. Close monitoring and following medical advice are key factors in achieving positive outcomes.[2][3]

Ongoing Clinical Trials on Acquired antithrombin III deficiency

  • Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia France Lithuania Poland Romania +2

References

https://www.stoptheclot.org/news/antithrombin-deficiency/

https://my.clevelandclinic.org/health/diseases/22251-antithrombin-deficiency

https://emedicine.medscape.com/article/954688-overview

https://pubmed.ncbi.nlm.nih.gov/17600391/

https://emedicine.medscape.com/article/954688-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC10571690/

More information about
Acquired antithrombin III deficiency:

FAQ

What’s the difference between inherited and acquired antithrombin deficiency?

Inherited antithrombin deficiency is caused by a genetic mutation you’re born with, passed down from parents. Acquired antithrombin deficiency develops later in life due to medical conditions like liver disease, severe infections, kidney problems, or as a side effect of certain treatments. Unlike the inherited form which is lifelong, acquired deficiency may improve or resolve if the underlying condition is successfully treated.[3][4]

How accurate is the blood test for antithrombin deficiency?

The antithrombin assay blood test is quite accurate when performed under the right conditions. However, timing matters greatly because certain medications, particularly heparin, can temporarily lower antithrombin levels and affect test results. Your doctor needs to consider your current medications and medical conditions when interpreting the results. Normal levels range from 80% to 120%, and anything below this suggests deficiency.[3][2]

Do I need to prepare for antithrombin deficiency testing?

Generally, the antithrombin blood test doesn’t require special preparation like fasting. However, you should inform your doctor about all medications you’re taking, especially blood thinners, as these can affect the results. Your doctor may want to perform the test before starting certain treatments or may need to adjust the timing based on your current medications. A simple blood draw from your arm is all that’s needed.[2][3]

What causes acquired antithrombin deficiency?

Acquired antithrombin deficiency can result from several medical conditions. Common causes include liver disease (which affects antithrombin production), nephrotic syndrome (where protein is lost through the kidneys), severe infections like sepsis, disseminated intravascular coagulation, and complications from bone marrow transplantation. Major surgery, certain medications including oral contraceptives, and heparin therapy can also lower antithrombin levels.[3][4]

Can acquired antithrombin deficiency be cured?

Unlike inherited antithrombin deficiency which is permanent, acquired deficiency may be reversible if the underlying cause can be treated successfully. For example, if liver function improves or a severe infection is cleared, antithrombin levels may return to normal. However, in cases where the underlying condition is chronic or progressive, the deficiency may persist and require ongoing management with blood thinning medications and regular monitoring.[3][4]

🎯 Key takeaways

  • • Acquired antithrombin deficiency develops from medical conditions rather than genetics, meaning it may potentially be reversible unlike inherited forms
  • • A simple blood test measuring antithrombin levels is the primary diagnostic tool, but timing matters since medications can affect results
  • • Common causes include liver disease, severe infections, kidney problems, and certain medical treatments including bone marrow transplantation
  • • People with serious illnesses, those undergoing major surgery, or individuals on specific medications should be alert to symptoms of unusual blood clots
  • • Diagnostic imaging like Doppler ultrasound or lung scans may be needed to detect existing blood clots in the legs or lungs
  • • The condition increases risk for dangerous blood clots, but proper diagnosis and treatment can effectively prevent serious complications
  • • Clinical trial participation requires specific diagnostic testing and documentation of both antithrombin levels and the underlying condition
  • • Prognosis depends largely on treating the root cause, with potential for improvement if the underlying medical condition can be resolved

Connected medications: